Syncom Formulations (India) Limited (BOM:524470)
12.21
+0.45 (3.83%)
At close: Jan 22, 2026
BOM:524470 Revenue
Syncom Formulations (India) had revenue of 1.22B INR in the quarter ending September 30, 2025, with 18.96% growth. This brings the company's revenue in the last twelve months to 5.15B, up 56.87% year-over-year. In the fiscal year ending March 31, 2025, Syncom Formulations (India) had annual revenue of 4.65B with 76.55% growth.
Revenue (ttm)
5.15B
Revenue Growth
+56.87%
P/S Ratio
2.23
Revenue / Employee
6.92M
Employees
744
Market Cap
11.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.65B | 2.02B | 76.55% |
| Mar 31, 2024 | 2.63B | 391.33M | 17.45% |
| Mar 31, 2023 | 2.24B | 45.91M | 2.09% |
| Mar 31, 2022 | 2.20B | -251.42M | -10.27% |
| Mar 31, 2021 | 2.45B | 392.94M | 19.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bliss GVS Pharma | 8.60B |
| TTK Healthcare | 8.25B |
| Anuh Pharma | 7.30B |
| Venus Remedies | 6.99B |
| Lincoln Pharmaceuticals | 6.32B |
| Fermenta Biotech | 5.63B |
| Fredun Pharmaceuticals | 5.31B |
| Amrutanjan Health Care | 4.70B |